Why the study?
Atherosclerotic cardiovascular diseases remain the leading cause of morbidity and mortality, prompting the need to summarize recent evidence on standard modifiable cardiovascular risk factors and emerging non-traditional risk factors.
Answers are grounded in this paper and cite their sources.
This review highlights the importance of addressing both standard modifiable and non-traditional risk factors, such as inflammation and lipoprotein(a), to improve cardiovascular outcomes in ischemic heart disease.
Atherosclerotic cardiovascular diseases, including ischemic heart disease (IHD), remain the leading cause of morbidity and mortality worldwide and are typically induced by the detrimental effects of risk factors on the cardiovascular system. Although some risk factors, such as age and sex, are non-modifiable, the identification and therapeutic interventions against standard modifiable cardiovascular risk factors (SMuRFs), namely hypertension, dyslipidemia, diabetes, smoking, and obesity, contribute to improved cardiovascular outcomes. Beyond SMuRFs, non-traditional, potentially modifiable risk factors for IHD have been identified, such as inflammation, lipoprotein(a), and air pollution. This review article summarizes recent clinical evidence regarding SMuRFs and non-traditional risk factors for IHD and atherosclerotic cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: